tipten - New Portfolio

Darko Markovski

tipten
Individual Investor
Ranked #465,310 out of 794,584 TipRanks' Investors
Success Rate
17%
4 out of 23
profitable transactions
Average Return
-22.50%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 18.40%
6-Month Return-
12-Month Return-
YTD Return▼ 21.87%
Total Return▼ 27.73%

Best Trade

Opened at
Closed at-
Gain▲ 35.09%

Bio

Performance

26.01%0-26.01%
▲ 2.93%
▲ 2.10%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 3.10%
Oct 2024
▲ 26.01%
▲ 5.96%
▲ 2.89%
Nov 2024
▲ 5.33%
▼ 2.41%
▼ 7.22%
Dec 2024
▲ 5.87%
▲ 2.69%
▲ 0.55%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 2.19%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 10.90%
Mar 2025
▼ 4.32%
▼ 4.06%
▼ 10.84%
Apr 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 2.93%▲ 2.10%
▲ 10.00%▼ 0.89%▼ 3.10%
▲ 26.01%▲ 5.96%▲ 2.89%
▲ 5.33%▼ 2.41%▼ 7.22%
▲ 5.87%▲ 2.69%▲ 0.55%
▼ 12.86%▼ 1.27%▼ 2.19%
▼ 1.80%▼ 5.57%▼ 10.90%
▼ 4.32%▼ 4.06%▼ 10.84%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Ish.Frf Sp Tech
▼ 0.82%
2
Close
Nov 27, 2024
Vang S&P 500 Ptg.Shs Exchange Traded Fund USD
▲ 3.07%
2
Close
Nov 27, 2024
VanEck Semiconductor UCITS ETF Accum A USD
▼ 7.13%
2
Close
Nov 27, 2024
Regis
5.63%
▼ 26.85%
1
Open
Nov 27, 2024
Ceribell, Inc.
4.25%
▼ 36.06%
1
Open
Nov 27, 2024
Universal Technical Institute
6.48%
▼ 3.03%
1
Open
Nov 27, 2024
Illumina
3.42%
▼ 48.63%
1
Open
Nov 27, 2024
Centrus Energy
4.3%
▼ 34.02%
1
Open
Nov 27, 2024
Bill.com Holdings
2.86%
▼ 55.95%
1
Open
Nov 27, 2024
NRG Energy
6.05%
▼ 15.09%
1
Open
Nov 27, 2024
ON Semiconductor
3.11%
▼ 52.10%
1
Open
Nov 27, 2024
Adtran
5.62%
▼ 11.44%
1
Open
Nov 27, 2024
Crocs
5.96%
▼ 4.69%
1
Open
Nov 27, 2024
Fortinet
6.13%
▼ 9.94%
1
Open
Nov 27, 2024
Verona Pharma
8.87%
▲ 35.09%
1
Open
Nov 27, 2024
Inhibikase Therapeutics
5.17%
▼ 32.60%
1
Open
Nov 27, 2024
Core Scientific Inc
2.6%
▼ 59.46%
1
Open
Nov 27, 2024
PureCycle Technologies
3.04%
▼ 54.62%
1
Open
Nov 27, 2024
Aldeyra Therapeutics
2.5%
▼ 61.74%
1
Open
Nov 27, 2024
Mama's Creations
4.8%
▼ 28.99%
1
Open
Nov 27, 2024